B. Braun Melsungen AG

13 marketed · 11 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about B. Braun Melsungen AG

What are B. Braun Melsungen AG's marketed drugs?

Top marketed products include Albumin + electrolyte solution, balanced electrolyte solution, Balanced gelatine solution, HES 10%, HES 130/0.42 + electrolyte solution, HES 6%.

What is B. Braun Melsungen AG's pipeline?

B. Braun Melsungen AG has 11 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include compounded monobag, fish oil containing lipid emulsion, Gelaspan 4%, Gelofusine 4%.

Related